Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...

The Biden administration set up the U.S. AI Safety Institute, an office tasked with developing protocols to identify risks posed by AI. Canada, Japan, Singapore, South Korea, the United Kingdom, and ...

Ooops... Something went wrong while loading this page.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.32, marking a -3.36% move from the previous day. This change lagged the S&P 500's daily loss of 0.13%. On the other hand, ...

Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder's research team built a new secrets detection method and scanned 5 ...

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

Strip the types and hotwire the HTML—and triple check your package security while you are at it. JavaScript in 2026 is just getting started. I am loath to inform you that the first month of 2026 has ...

Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...

The reason why this nascent startup had VCs lining up is the founders.They are so famed in the AI world, everyone tried to hire them.